Tag: Prescription Drugs

One-year outcomes similar for cycling JAK inhibitors versus switching to a biologic drug

Interim analysis shows lower risk for progression with sotrovimab versus placebo among high-risk patients with mild-to-moderate COVID-19

Incidence of events indicating loss of asthma control lower with itepekimab monotherapy in phase 2, proof-of-concept trial

Royalty-free license means companies in 105 countries can sublicense the formulation for antiviral pill molnupiravir and start making it

For hospitalized adults with COVID-19, time to recovery did not differ with interferon beta-1a plus remdesivir versus remdesivir alone

Lower serum IgG anti-dsDNA antibody levels seen at 52 weeks with belimumab rather than placebo given after rituximab

In phase 2b trial, more patients with active NASH had reduction in disease activity score with lanifibranor versus placebo

For older adults hospitalized with common medical conditions, intensifying diabetes meds at time of discharge shows little benefit

In August 2021, 21 calls were received by Oregon Poison Center; six people were hospitalized for toxic effects resulting from use

Risk for preterm birth increased with antirheumatic treatment for psoriatic arthritis -- particularly biologics -- during pregnancy